EMEA (Europe, Middle East and Africa) Antibody Drug Conjugates Market Report 2019

Table of Contents

EMEA (Europe, Middle East and Africa) Antibody Drug Conjugates Market Report 2017
1 Antibody Drug Conjugates Overview
1.1 Product Overview and Scope of Antibody Drug Conjugates
1.2 Classification of Antibody Drug Conjugates
1.2.1 EMEA Antibody Drug Conjugates Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Antibody Drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Adcetris
1.2.4 Kadcyla
1.3 EMEA Antibody Drug Conjugates Market by Application/End Users
1.3.1 EMEA Antibody Drug Conjugates Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 EMEA Antibody Drug Conjugates Market by Region
1.4.1 EMEA Antibody Drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antibody Drug Conjugates (2012-2022)
1.5.1 EMEA Antibody Drug Conjugates Sales and Growth Rate (2012-2022)
1.5.2 EMEA Antibody Drug Conjugates Revenue and Growth Rate (2012-2022)

2 EMEA Antibody Drug Conjugates Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Antibody Drug Conjugates Market Competition by Players/Manufacturers
2.1.1 EMEA Antibody Drug Conjugates Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Antibody Drug Conjugates Revenue and Share by Players (2012-2017)
2.1.3 EMEA Antibody Drug Conjugates Sale Price by Players (2012-2017)
2.2 EMEA Antibody Drug Conjugates (Volume and Value) by Type/Product Category
2.2.1 EMEA Antibody Drug Conjugates Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Antibody Drug Conjugates Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Antibody Drug Conjugates Sale Price by Type (2012-2017)
2.3 EMEA Antibody Drug Conjugates (Volume) by Application
2.4 EMEA Antibody Drug Conjugates (Volume and Value) by Region
2.4.1 EMEA Antibody Drug Conjugates Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Antibody Drug Conjugates Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Antibody Drug Conjugates Sales Price by Region (2012-2017)

3 Europe Antibody Drug Conjugates (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Antibody Drug Conjugates Sales and Value (2012-2017)
3.1.1 Europe Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
3.2 Europe Antibody Drug Conjugates Sales and Market Share by Type
3.3 Europe Antibody Drug Conjugates Sales and Market Share by Application
3.4 Europe Antibody Drug Conjugates Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Antibody Drug Conjugates Sales Volume by Countries (2012-2017)
3.4.2 Europe Antibody Drug Conjugates Revenue by Countries (2012-2017)
3.4.3 Germany Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
3.4.4 France Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
3.4.5 UK Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
3.4.6 Russia Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
3.4.7 Italy Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
3.4.8 Benelux Antibody Drug Conjugates Sales and Growth Rate (2012-2017)

4 Middle East Antibody Drug Conjugates (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Antibody Drug Conjugates Sales and Value (2012-2017)
4.1.1 Middle East Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
4.2 Middle East Antibody Drug Conjugates Sales and Market Share by Type
4.3 Middle East Antibody Drug Conjugates Sales and Market Share by Application
4.4 Middle East Antibody Drug Conjugates Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Antibody Drug Conjugates Sales Volume by Countries (2012-2017)
4.4.2 Middle East Antibody Drug Conjugates Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
4.4.4 Israel Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
4.4.5 UAE Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
4.4.6 Iran Antibody Drug Conjugates Sales and Growth Rate (2012-2017)

5 Africa Antibody Drug Conjugates (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Antibody Drug Conjugates Sales and Value (2012-2017)
5.1.1 Africa Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
5.2 Africa Antibody Drug Conjugates Sales and Market Share by Type
5.3 Africa Antibody Drug Conjugates Sales and Market Share by Application
5.4 Africa Antibody Drug Conjugates Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Antibody Drug Conjugates Sales Volume by Countries (2012-2017)
5.4.2 Africa Antibody Drug Conjugates Revenue by Countries (2012-2017)
5.4.3 South Africa Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
5.4.5 Egypt Antibody Drug Conjugates Sales and Growth Rate (2012-2017)
5.4.6 Algeria Antibody Drug Conjugates Sales and Growth Rate (2012-2017)

6 EMEA Antibody Drug Conjugates Manufacturers/Players Profiles and Sales Data
6.1 F.Hoffman-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antibody Drug Conjugates Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 F.Hoffman-La Roche Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Antibody Drug Conjugates Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceutial
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Antibody Drug Conjugates Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Takeda Pharmaceutial Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Antibody Drug Conjugates Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Seattle Genetics
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Antibody Drug Conjugates Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Genentech
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Antibody Drug Conjugates Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Genentech Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Immunogen
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Antibody Drug Conjugates Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Immunogen Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Immunomedics
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Antibody Drug Conjugates Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Immunomedics Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Progenics Pharmaceutical
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Antibody Drug Conjugates Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Progenics Pharmaceutical Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bayer Healthcare Pharmaceutical
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Antibody Drug Conjugates Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Agensys
6.12 Concortis Biotherapeutics
6.13 Sanofi
6.14 Celldex Therapeutics
6.15 Synthon Holding

7 Antibody Drug Conjugates Manufacturing Cost Analysis
7.1 Antibody Drug Conjugates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibody Drug Conjugates

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antibody Drug Conjugates Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Antibody Drug Conjugates Market Forecast (2017-2022)
11.1 EMEA Antibody Drug Conjugates Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Antibody Drug Conjugates Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Antibody Drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Antibody Drug Conjugates Price and Trend Forecast (2017-2022)
11.2 EMEA Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antibody Drug Conjugates Sales Forecast by Type (2017-2022)
11.7 EMEA Antibody Drug Conjugates Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Antibody Drug Conjugates
Figure EMEA Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Antibody Drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016
Figure Adcetris Product Picture
Figure Kadcyla Product Picture
Figure EMEA Antibody Drug Conjugates Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Antibody Drug Conjugates by Application in 2016
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure EMEA Antibody Drug Conjugates Market Size (Million USD) by Region (2012-2022)
Figure Europe Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody Drug Conjugates Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antibody Drug Conjugates Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antibody Drug Conjugates Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antibody Drug Conjugates Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Antibody Drug Conjugates Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Antibody Drug Conjugates Sales Share by Players (2012-2017)
Figure 2016 Antibody Drug Conjugates Sales Share by Players
Figure 2017 Antibody Drug Conjugates Sales Share by Players
Figure EMEA Antibody Drug Conjugates Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antibody Drug Conjugates Revenue (Million USD) by Players (2012-2017)
Table EMEA Antibody Drug Conjugates Revenue Share by Players (2012-2017)
Table 2016 EMEA Antibody Drug Conjugates Revenue Share by Players
Table 2017 EMEA Antibody Drug Conjugates Revenue Share by Players
Table EMEA Antibody Drug Conjugates Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Antibody Drug Conjugates Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugates Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugates by Type (2012-2017)
Figure EMEA Antibody Drug Conjugates Sales Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugates Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugates by Type in 2016
Table EMEA Antibody Drug Conjugates Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Antibody Drug Conjugates Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Antibody Drug Conjugates Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugates by Application (2012-2017)
Figure EMEA Antibody Drug Conjugates Sales Market Share by Application in 2016
Table EMEA Antibody Drug Conjugates Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Antibody Drug Conjugates Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugates by Region (2012-2017)
Figure EMEA Antibody Drug Conjugates Sales Market Share in 2016
Table EMEA Antibody Drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antibody Drug Conjugates Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugates by Region (2012-2017)
Figure EMEA Antibody Drug Conjugates Revenue Market Share Regions in 2016
Table EMEA Antibody Drug Conjugates Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
Table Europe Antibody Drug Conjugates Sales (K Units) by Type (2012-2017)
Table Europe Antibody Drug Conjugates Market Share by Type (2012-2017)
Figure Europe Antibody Drug Conjugates Market Share by Type in 2016
Table Europe Antibody Drug Conjugates Sales (K Units) by Application (2012-2017)
Table Europe Antibody Drug Conjugates Market Share by Application (2012-2017)
Figure Europe Antibody Drug Conjugates Market Share by Application in 2016
Table Europe Antibody Drug Conjugates Sales (K Units) by Countries (2012-2017)
Table Europe Antibody Drug Conjugates Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugates Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugates Sales Market Share by Countries in 2016
Table Europe Antibody Drug Conjugates Revenue (Million USD) by Countries (2012-2017)
Table Europe Antibody Drug Conjugates Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugates Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugates Revenue Market Share by Countries in 2016
Figure Germany Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure France Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure UK Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antibody Drug Conjugates Sales (K Units) by Type (2012-2017)
Table Middle East Antibody Drug Conjugates Market Share by Type (2012-2017)
Figure Middle East Antibody Drug Conjugates Market Share by Type (2012-2017)
Table Middle East Antibody Drug Conjugates Sales (K Units) by Applications (2012-2017)
Table Middle East Antibody Drug Conjugates Market Share by Applications (2012-2017)
Figure Middle East Antibody Drug Conjugates Sales Market Share by Application in 2016
Table Middle East Antibody Drug Conjugates Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Antibody Drug Conjugates Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugates Sales Volume Market Share by Countries in 2016
Table Middle East Antibody Drug Conjugates Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antibody Drug Conjugates Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugates Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugates Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antibody Drug Conjugates Sales (K Units) by Type (2012-2017)
Table Africa Antibody Drug Conjugates Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drug Conjugates Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drug Conjugates Sales Market Share by Type in 2016
Table Africa Antibody Drug Conjugates Sales (K Units) by Application (2012-2017)
Table Africa Antibody Drug Conjugates Sales Market Share by Application (2012-2017)
Figure Africa Antibody Drug Conjugates Sales Market Share by Application (2012-2017)
Table Africa Antibody Drug Conjugates Sales Volume (K Units) by Countries (2012-2017)
Table Africa Antibody Drug Conjugates Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugates Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugates Sales Market Share by Countries in 2016
Table Africa Antibody Drug Conjugates Revenue (Million USD) by Countries (2012-2017)
Table Africa Antibody Drug Conjugates Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugates Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugates Revenue Market Share by Countries in 2016
Figure South Africa Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Table F.Hoffman-La Roche Antibody Drug Conjugates Basic Information List
Table F.Hoffman-La Roche Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Novartis Antibody Drug Conjugates Basic Information List
Table Novartis Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Novartis Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutial Antibody Drug Conjugates Basic Information List
Table Takeda Pharmaceutial Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Pfizer Antibody Drug Conjugates Basic Information List
Table Pfizer Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Pfizer Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Seattle Genetics Antibody Drug Conjugates Basic Information List
Table Seattle Genetics Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Genentech Antibody Drug Conjugates Basic Information List
Table Genentech Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Genentech Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Genentech Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Immunogen Antibody Drug Conjugates Basic Information List
Table Immunogen Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunogen Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Immunogen Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Immunogen Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Immunomedics Antibody Drug Conjugates Basic Information List
Table Immunomedics Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Progenics Pharmaceutical Antibody Drug Conjugates Basic Information List
Table Progenics Pharmaceutical Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Basic Information List
Table Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales Market Share in EMEA (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Revenue Market Share in EMEA (2012-2017)
Table Agensys Antibody Drug Conjugates Basic Information List
Table Concortis Biotherapeutics Antibody Drug Conjugates Basic Information List
Table Sanofi Antibody Drug Conjugates Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugates Basic Information List
Table Synthon Holding Antibody Drug Conjugates Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugates
Figure Manufacturing Process Analysis of Antibody Drug Conjugates
Figure Antibody Drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016
Table Major Buyers of Antibody Drug Conjugates
Table Distributors/Traders List
Figure EMEA Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drug Conjugates Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Antibody Drug Conjugates Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Antibody Drug Conjugates Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antibody Drug Conjugates Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antibody Drug Conjugates Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antibody Drug Conjugates Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Antibody Drug Conjugates Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antibody Drug Conjugates Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antibody Drug Conjugates Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drug Conjugates Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drug Conjugates Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drug Conjugates Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drug Conjugates Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drug Conjugates Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Antibody Drug Conjugates Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drug Conjugates Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antibody Drug Conjugates Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antibody Drug Conjugates Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Antibody Drug Conjugates Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antibody Drug Conjugates Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Antibody Drug Conjugates Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources